title: [Long-term effects of botulinum toxin treatment].
abstract: Long-term BoNT treatment administration has been assessed in various treatment settings (especially in neurology), with the level and duration of BoNT efficacy response being maintained with no major safety problems. Most side effects are local one and are transient. The incidence of antibody development is low and does not induce significant concerns in clinical practice.
authors: Service de neurologie, CNRS UMR 8160, CHU d'Amiens, 80054 Amiens cedex. krystkowiak.pierre@chu-amiens.fr
authors: P
authors: P
authors: Krystkowiak
mesh_terms: D000917:Antibody Formation / Q000187:drug effects; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D005145:Face; D006801:Humans; D007267:Injections / Q000379:methods; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015595:Skin Aging / Q000187:drug effects* / Q000276:immunology; D013995:Time
chemical_list: D003879:Dermatologic Agents; D009465:Neuromuscular Agents; D001905:Botulinum Toxins